Functional Landscape of SARS-CoV-2 Cellular Restriction
L. Martin-Sancho, M. K. Lewinski, L. Pache, C. Stoneham, X. YIN, D. Pratt, C. Churas, S. B. Rosenthal, S. Liu, P. D. De Jesus, A. M. O'Neill, A. P. Gounder, C. Nguyen, Y. Pu, A. L. Oom, L. Miorin, A. Rodriguez-Frandsen, M. Urbanowski, M. L. Shaw, M. W. Chang, C. Benner, M. Frieman, A. Garcia-Sastre, T. Ideker, J. F. Hultquist, , S. Chanda
Abstract
A deficient interferon response to SARS-CoV-2 infection has been implicated as a determinant of severe COVID-19. To identify the molecular effectors that govern interferon control of SARS-CoV-2 infection, we conducted a large-scale gain-of-function analysis that evaluated the impact of human interferon stimulated genes (ISGs) on viral replication. A limited subset of ISGs were found to control viral infection, including endosomal factors that inhibited viral entry, nucleic acid binding proteins that suppressed viral RNA synthesis, and a highly enriched cluster of ER and Golgi-resident ISGs that inhibited viral translation and egress. These included the type II integral membrane protein BST2/tetherin, which was found to impede viral release, and is targeted for immune evasion by SARS-CoV-2 Orf7a protein. Overall, these data define the molecular basis of early innate immune control of viral infection, which will facilitate the understanding of host determinants that impact disease severity and offer potential therapeutic strategies for COVID-19.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells
- SARS-CoV-2 S protein antagonizes type I interferon downstream signal pathway through interacting and attenuating phosphorylation of STAT1/STAT2
- SARS-CoV-2 replication triggers an MDA-5-dependent interferon production which is unable to efficiently control replication
A. Rebendenne, A. L. Chaves Valadao, … C. Goujon·bioRxiv·Oct 28, 2020
- Pre-existing interferon gamma conditions the lung to mediate early control of SARS-CoV-2
K. L. Hilligan, S. Namasivayam, … A. Sher·bioRxiv·Jul 15, 2023
- SARS-CoV-2 ORF9b Antagonizes Type I and III Interferons by Targeting Multiple Components of RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING Signaling Pathways
L. Han, M.-W. Zhuang, … C. Gao·bioRxiv·Aug 16, 2020
- Experimental and natural evidence of SARS-CoV-2 infection-induced activation of type I interferon responses
A. Banerjee, N. El-Sayes, … K. Mossman·bioRxiv·Jun 18, 2020